PAR-21-300 - NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk |
NOT-CA-24-037 |
NCI
|
Mar 7, 2024 |
May 9, 2026
|
K08, K22, R01, K99/R00, R21, P01 |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity
and Prostate Cancer Risk |
NOT-CA-23-089 |
NCI
|
Aug 30, 2023 |
Sep 8, 2024
|
R01, K99/R00, R21, K08, K22 |
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer |
NOT-CA-23-018 |
NCI
|
Jan 19, 2023 |
Sep 8, 2024
|
K01, R01, K22, K08, R21, U34, K99/R00, P01, R34 |
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute |
NOT-CA-23-035 |
NCI
|
Jan 18, 2023 |
Nov 13, 2024
|
K22, K08, K99/R00, K01 |
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer |
NOT-CA-22-085 |
NCI
|
May 5, 2022 |
Jul 5, 2027
|
K22, R01, K08, K01, R21, R03, K99/R00 |
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy |
NOT-CA-22-063 |
NCI , NIAID , NIAMS , NIDCR
|
May 3, 2022 |
Jul 5, 2024
|
R01, R21, K99/R00, K01, K08, K22, R03, R15 |
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention |
NOT-CA-21-121 |
NCI
|
Oct 4, 2021 |
Sep 8, 2024
|
K22, K08, R15, R01, R21, K99/R00, |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
|